A new drug has been found to significantly lower blood pressure in people with dangerously high levels despite taking several existing medicines, an advance that could help address hard-to-treat hypertension cases.
Around half of the global 1.3 billion high blood pressure cases are treatment-resistant, with such patients facing a much greater risk of heart attack, stroke, kidney disease, and early death.
